Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.
Baas P, Belderbos JS, Senan S, Kwa HB, van Bochove A, van Tinteren H, Burgers JA, van Meerbeeck JP. Baas P, et al. Among authors: van bochove a, van meerbeeck jp, van tinteren h. Br J Cancer. 2006 Mar 13;94(5):625-30. doi: 10.1038/sj.bjc.6602979. Br J Cancer. 2006. PMID: 16465191 Free PMC article. Clinical Trial.
Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer.
de Jong WK, Groen HJ, Koolen MG, Biesma B, Willems LN, Kwa HB, van Bochove A, van Tinteren H, Smit EF. de Jong WK, et al. Among authors: van bochove a, van tinteren h. Eur J Cancer. 2007 Nov;43(16):2345-50. doi: 10.1016/j.ejca.2007.07.029. Epub 2007 Sep 10. Eur J Cancer. 2007. PMID: 17826977 Clinical Trial.
Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
Graf N, van Tinteren H, Bergeron C, Pein F, van den Heuvel-Eibrink MM, Sandstedt B, Schenk JP, Godzinski J, Oldenburger F, Furtwängler R, de Kraker J. Graf N, et al. Among authors: van den heuvel eibrink mm, van tinteren h. Eur J Cancer. 2012 Nov;48(17):3240-8. doi: 10.1016/j.ejca.2012.06.007. Epub 2012 Jul 12. Eur J Cancer. 2012. PMID: 22795263 Clinical Trial.
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.
Drukker CA, Bueno-de-Mesquita JM, Retèl VP, van Harten WH, van Tinteren H, Wesseling J, Roumen RM, Knauer M, van 't Veer LJ, Sonke GS, Rutgers EJ, van de Vijver MJ, Linn SC. Drukker CA, et al. Among authors: van harten wh, van t veer lj, van de vijver mj, van tinteren h. Int J Cancer. 2013 Aug 15;133(4):929-36. doi: 10.1002/ijc.28082. Epub 2013 Mar 4. Int J Cancer. 2013. PMID: 23371464 Free PMC article.
Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
Furtwängler R, Gooskens SL, van Tinteren H, de Kraker J, Schleiermacher G, Bergeron C, de Camargo B, Acha T, Godzinski J, Sandstedt B, Leuschner I, Vujanic GM, Pieters R, Graf N, van den Heuvel-Eibrink MM. Furtwängler R, et al. Among authors: van den heuvel eibrink mm, van tinteren h. Eur J Cancer. 2013 Nov;49(16):3497-506. doi: 10.1016/j.ejca.2013.06.036. Epub 2013 Jul 20. Eur J Cancer. 2013. PMID: 23880476
Prospective cost-effectiveness analysis of genomic profiling in breast cancer.
Retèl VP, Joore MA, Drukker CA, Bueno-de-Mesquita JM, Knauer M, van Tinteren H, Linn SC, van Harten WH. Retèl VP, et al. Among authors: van harten wh, van tinteren h. Eur J Cancer. 2013 Dec;49(18):3773-9. doi: 10.1016/j.ejca.2013.08.001. Epub 2013 Aug 27. Eur J Cancer. 2013. PMID: 23992641
327 results